Capital Analysts LLC’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.7M Buy
38,133
+3,126
+9% +$234K 0.07% 223
2025
Q4
$2.76M Buy
35,007
+1,711
+5% +$135K 0.08% 208
2025
Q3
$2.74M Sell
33,296
-1,712
-5% -$135K 0.08% 199
2025
Q2
$2.81M Buy
35,008
+39
+0.1% +$3.01K 0.09% 174
2025
Q1
$2.81M Buy
34,969
+241
+0.7% +$20K 0.1% 162
2024
Q4
$2.84M Sell
34,728
-769
-2% -$64K 0.11% 147
2024
Q3
$2.93M Buy
35,497
+261
+0.7% +$19.5K 0.12% 146
2024
Q2
$2.47M Buy
35,236
+393
+1% +$28.1K 0.11% 157
2024
Q1
$2.58M Buy
34,843
+834
+2% +$58.1K 0.12% 144
2023
Q4
$2.25M Sell
34,009
-1,439
-4% -$90.1K 0.11% 151
2023
Q3
$2.23M Buy
35,448
+383
+1% +$23.9K 0.12% 137
2023
Q2
$1.98M Buy
35,065
+1,088
+3% +$60.4K 0.11% 163
2023
Q1
$1.97M Buy
33,977
+1,450
+4% +$97.9K 0.11% 160
2022
Q4
$2.35M Sell
32,527
-193
-0.6% -$13.8K 0.14% 142
2022
Q3
$1.99M Buy
32,720
+1,542
+5% +$98.5K 0.14% 144
2022
Q2
$1.96M Buy
31,178
+1,352
+5% +$89.5K 0.14% 150
2022
Q1
$2.1M Sell
29,826
-193
-0.6% -$13K 0.13% 148
2021
Q4
$1.88M Buy
30,019
+872
+3% +$54.7K 0.11% 166
2021
Q3
$1.8M Sell
29,147
-967
-3% -$58.2K 0.12% 160
2021
Q2
$1.8M Sell
30,114
-651
-2% -$41.3K 0.12% 160
2021
Q1
$1.87M Sell
30,765
-5,149
-14% -$284K 0.13% 149
2020
Q4
$1.69M Sell
35,914
-2,707
-7% -$117K 0.15% 123
2020
Q3
$1.44M Buy
38,621
+926
+2% +$35.1K 0.14% 136
2020
Q2
$1.38M Sell
37,695
-164
-0.4% -$5.71K 0.14% 131
2020
Q1
$1.16M Buy
37,859
+2,219
+6% +$98.4K 0.14% 130
2019
Q4
$1.82M Sell
35,640
-244
-0.7% -$11.8K 0.18% 104
2019
Q3
$1.69M Buy
35,884
+581
+2% +$27.7K 0.18% 102
2019
Q2
$1.75M Sell
35,303
-718
-2% -$33.7K 0.19% 98
2019
Q1
$1.53M Buy
36,021
+5,608
+18% +$248K 0.18% 102
2018
Q4
$1.25M Buy
30,413
+27,566
+968% +$1.18M 0.16% 108
2018
Q3
$133K Hold
2,847
0.02% 221
2018
Q2
$124K Hold
2,847
0.01% 228
2018
Q1
$131K Buy
2,847
+807
+40% +$39.2K 0.02% 213
2017
Q4
$103K Buy
2,040
+20
+1% +$1.05K 0.01% 233
2017
Q3
$105K Sell
2,020
-246
-11% -$12K 0.01% 239
2017
Q2
$111K Hold
2,266
0.02% 226
2017
Q1
$107K Hold
2,266
0.02% 204
2016
Q4
$109K Sell
2,266
-40
-2% -$1.83K 0.02% 212
2016
Q3
$91.3K Sell
2,306
-179
-7% -$6.73K 0.02% 215
2016
Q2
$88.2K Buy
2,485
+397
+19% +$15.5K 0.02% 217
2016
Q1
$81.8K Sell
2,088
-59,582
-97% -$2.23M 0.02% 228
2015
Q4
$2.65M Buy
61,670
+1,713
+3% +$75.3K 0.54% 44
2015
Q3
$2.52M Buy
59,957
+3,196
+6% +$149K 0.48% 58
2015
Q2
$2.83M Buy
56,761
+2,874
+5% +$136K 0.58% 35
2015
Q1
$2.43M Buy
53,887
+2,737
+5% +$123K 0.51% 48
2014
Q4
$2.47M Buy
51,150
+2,560
+5% +$122K 0.54% 44
2014
Q3
$2.33M Buy
48,590
+5,575
+13% +$271K 0.55% 43
2014
Q2
$2.13M Buy
43,015
+271
+0.6% +$12.7K 0.52% 45
2014
Q1
$2.01M Sell
42,744
-4,232
-9% -$195K 0.53% 43
2013
Q4
$2.26M Buy
46,976
+508
+1% +$22.8K 0.61% 35
2013
Q3
$1.94M Sell
46,468
-3,506
-7% -$151K 0.58% 39
2013
Q2
$2.04M Buy
+49,974
New +$1.84M 0.64% 36

Other funds holding MET

Capital Analysts LLC's MET Position: Q1 2026 in Review

Capital Analysts LLC increased its MetLife (MET) stake by 8.9% in Q1 2026, buying an estimated $234K and bringing the position to 38,133 shares worth $2.7M. The position accounts for 0.07% of the portfolio, ranked #223.

Capital Analysts LLC first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.93M in Q3 2024. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Capital Analysts LLC held 38,133 shares of MetLife worth $2.7M as of Q1 2026.
  • Capital Analysts LLC bought 3,126 MetLife shares in Q1 2026, an estimated $234K.
  • MetLife made up 0.07% of Capital Analysts LLC's portfolio in Q1 2026, its #223 holding.
  • Capital Analysts LLC first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
  • Capital Analysts LLC's MetLife position peaked at $2.93M in Q3 2024.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Capital Analysts LLC's 13F filing for Q1 2026, filed 14 May 2026.